OVERVIEW OF THE KEY AMENDMENTS TO THE RULES OF THE STATE REGISTRATION OF MAXIMUM SELLING PRICES FOR MEDICINES INCLUDED INTO THE LIST OF ESSENTIAL AND VITALLY IMPORTANT PRODUCTS
In this article we analyse key amendments that came into force as of October 2015 in the sphere of the price regulation for medicines included into the list of essential and vitally important products.
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/217 |